CZR
Caesars Entertainment, Inc.
CZR has a slight edge over F overall, supported by stronger fundamentals and lower modeled downside.
F
Ford Motor Company
F offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
CZR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Under pressure |
CZR's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CZR PE Valuation
CZR has no meaningful PE right now: it lost money over the past year.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CZR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect CZR's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
F has the edge over CZR on the outlook, with more favorable earnings and profitability expectations.
CZR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.61 | -$1.45 |
| Q2 2026 | -$2.27 | -$1.34 |
| Q1 2026 | -$2.36 | -$1.26 |
| Q4 2025 | -$2.42 | -$1.13 |
| Q3 2025 | -$1.16 | +$0.50 |
| Q2 2025 | -$0.93 | +$0.35 |
| Q1 2025 | -$1.10 | -131% |
| Q4 2024 | -$1.29 | -135% |
CZR is still losing money, but far less than before: $2.61 per share over the past year, against $13.50 at its worst in late 2020.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has the edge over CZR on earnings, with more consistent year-over-year improvement.
CZR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.9B | +2.5% |
| Q2 2026 | $3B | +3% |
| Q1 2026 | $2.9B | +2.7% |
| Q4 2025 | $2.9B | +4.2% |
| Q3 2025 | $2.9B | -0.2% |
| Q2 2025 | $2.9B | +2.7% |
| Q1 2025 | $2.8B | +1.9% |
| Q4 2024 | $2.8B | -0.9% |
CZR has the edge over F on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -2.3 points |
| Q2 2026 | 17% | -0.9 points |
| Q1 2026 | 17% | 0 points |
| Q4 2025 | 11% | -13 points |
| Q3 2025 | 18% | -4.5 points |
| Q2 2025 | 18% | +0.2 points |
| Q1 2025 | 17% | -0.2 points |
| Q4 2024 | 24% | +4.9 points |
CZR has the edge over F on profitability, with a higher operating margin.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
CZR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $95M | -23% |
| Q2 2026 | $304M | +31% |
| Q1 2026 | $36M | +$41M |
| Q4 2025 | $147M | +390% |
| Q3 2025 | $123M | +$315M |
| Q2 2025 | $232M | +86% |
| Q1 2025 | -$5M | +$179M |
| Q4 2024 | $30M | -78% |
CZR has the edge over F on cash flow, with more consistent year-over-year improvement.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
CZR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 3.3x | Elevated |
| Q1 2026 | 3.3x | Elevated |
| Q4 2025 | 3.3x | Elevated |
| Q3 2025 | 3.0x | Elevated |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.1x | Elevated |
CZR's net debt is about 3.3 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over CZR on leverage, with a lower net debt burden relative to earnings.
CZR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 38.6 | Neutral |
CZR's weekly RSI is 55 (neutral) and its Stochastic is 39 (neutral).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CZR PE vs Consumer Cyclical Sector
| Metric | CZR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CZR has no meaningful PE right now: it lost money over the past year.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CZR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.2 | 0.1% above |
| 20 week MA | $29.6 | 1.1% below |
| 50 week MA | $27.3 | 7.2% above |
| 100 week MA | $27.6 | 6.3% above |
| 200 week MA | $35.7 | 18% below |
CZR has the edge over F on trend strength, trading above more of its moving averages.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CZR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.2 | $75.8 | +28% |
| 2021 | $75.8 | $94.8 | +25% |
| 2022 | $94.8 | $43.1 | -55% |
| 2023 | $43.1 | $46.9 | +8.8% |
| 2024 | $46.9 | $33.1 | -29% |
| 2025 | $33.1 | $24.8 | -25% |
| 2026 YTD | $24.8 | $29.3 | +18% |
CZR has the edge over F on returns for 2026, with the stronger performance.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.